Recent News

• 06.03.2025 - Traws Pharma Announces Publication of Compelling Efficacy data in RDEB SCC Patients Treated with Legacy Oncology Drug Rigosertib
• 06.03.2025 - Traws Pharma Announces Publication of Compelling Efficacy data in RDEB SCC Patients Treated with Legacy Oncology Drug Rigosertib
• 05.27.2025 - Traws Pharma Announces Receipt of FDA Guidance on Tivoxavir Marboxil and Reports Plans for Pursuing Stockpiling for Pandemic Preparedness
• 05.27.2025 - Traws Pharma Announces Receipt of FDA Guidance on Tivoxavir Marboxil and Reports Plans for Pursuing Stockpiling for Pandemic Preparedness
• 05.15.2025 - Traws Pharma Reports First Quarter 2025 Results and Business Highlights
• 05.15.2025 - Traws Pharma Reports First Quarter 2025 Results and Business Highlights

Recent Filings

• 06.03.2025 - EX-99.1 EX-99.1
• 06.03.2025 - 8-K Current report
• 05.27.2025 - 8-K Current report
• 05.27.2025 - EX-99.1 EX-99.1
• 05.19.2025 - 8-K Current report
• 05.19.2025 - EX-99.1 EX-99.1
• 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.15.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.15.2025 - 8-K Current report
• 05.15.2025 - EX-99.1 EX-99.1